Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2017

Feb 2, 2017

29777_dirs_2017-02-02_eb7df2c4-8c48-45b8-98dc-6e11e1eb105f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-01-31

Reporting Person: Mason Heather L (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-01-31 Common shares without par value M 35700 $25.2461 Acquired 100189 Direct
2017-01-31 Common shares without par value S 35700 $40.77 Disposed 64489 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-01-31 Option (right to buy) $25.2461 M 35700 Disposed 2017-02-15 Common shares (35700) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 70000 Indirect

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.